Inverness Medical Innovations
Secretary-General's statement following meeting with pharmaceutical and diagnostic companies working on HIV and AIDS
Author: United Nations
I met today with senior executives of seventeen of the world's research-based and generic pharmaceutical and diagnostic companies…to review progress on...expand[ing] access to HIV prevention, treatment, care and support services in low- and middle...
- Related stories: Major drug firms agree with Ban Ki-Moon to invest more in AIDS treatments & diagnostics for poor regions
- Related in-depth areas: HIV/AIDS
- Related companies: Abbott Laboratories AMB Generali Aspen Pharmacare Aurobindo Pharmaceuticals BD (Becton, Dickinson) bioMérieux Boehringer Ingelheim Gilead Sciences GlaxoSmithKline Hetero Inverness Medical Innovations Johnson & Johnson Matrix Laboratories (part of Mylan Laboratories) Merck Pfizer Ranbaxy Laboratories Roche Shanghai Kehua Bio-Engineering
New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-line Drugs - Agreements with Nine Companies Will Lower Prices of HIV Diagnosis and Two HIV/AIDS Medicines by 30-50 Percent for 50 Countries
Author: Clinton Foundation
President Bill Clinton announced today that his foundation’s HIV/AIDS Initiative has negotiated new pricing agreements to lower the prices of HIV diagnosis and two antiretrovirals (ARVs). Four companies—Chembio (U.S.), Orgenics (Israel; a subsidiary...